Successful suppression using Rituximab of a factor VIII inhibitor in a boy with severe congenital haemophilia: an example of a significant decrease of treatment costs

Thromb Haemost. 2006 Feb;95(2):386-7.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Autoantibodies / blood*
  • B-Lymphocytes / drug effects
  • Factor VIII / immunology*
  • Health Care Costs
  • Hemophilia A / drug therapy*
  • Hemophilia A / economics
  • Humans
  • Infant
  • Male
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Autoantibodies
  • Rituximab
  • Factor VIII